Last updated on July 2019
Study to Assess the Efficacy and Safety of CLBS12 in Patients With Critical Limb Ischemia (CLI)
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Critical Limb Ischemia | Thromboangiitis Obliterans | Atherosclerosis Obliterans
-
Age: Between 20 - 80 Years
-
Gender: Male or Female
Inclusion Criteria:
- subject has CLI caused by ASO or BD
Exclusion Criteria:
- < 20 years old